Patent 11077197 was granted and assigned to Arbutus Biopharma Corporation on August, 2021 by the United States Patent and Trademark Office.
The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention